Starting Residency? What dermatology thought leaders want you to know
Starting Residency? During the 2018 Skin of Color Seminar Series(now the Skin of Color Update), Next Steps correspondent, Brianna Olamiju, spoke with some of the top dermatology thought leaders about what you should know.
What are three pieces of advice you would give to an individual entering dermatology residency?
Dr. Ted Rosen:
Work towards developingan area of significant expertis …
Starting Residency? During the 2018 Skin of Color Seminar Series(now the Skin of Color Update), Next Steps correspondent, Brianna Olamiju, spoke with some of the top dermatology thought leaders about what you should know.
What are three pieces of advice you would give to an individual entering dermatology residency?
Dr. Ted Rosen:
Work towards developingan area of significant expertis … Continue reading "Starting Residency? What dermatology thought leaders want you to know"
A patient presents with nail findings seen here. Biopsy demonstrates fungus. The patient recently saw an add for a medication, Jublia (Efinaconazole). What is the medication of action?
A. Antifungal via inhibiting fungal lanosterol 14-alpha-demethylase
B. Inhibits squalene epoxidase
C. Inhibits DNA gyrase
D. Inhibits epithelial sodium channels
E. Binds ergosterol and forms por … 
We are excited to announce another installment of our new recurring series: Ask a Mentor. In this monthly segment, we will identify an accomplished mentor in the field of Dermatology to answer your questions about career development and their unique areas of expertise.
If you have questions on finding a niche in the field, developing a career in academics and/or better serving patients of color … 
Which of the following is true about this condition?
A. Histology will show amastagotes in plasma cells.
B. Cuture is performed on MacConkey agar.
C. Diagnosis may be made by sending a sample
for real-time PCR assay to the Centers for Disease Control and Prevention.
D. This condition does not typically resolve without treatment.
E. Treatment for cutaneous and … 
An 80-year-old man with Parkinson’s disease developed a new pruritic eruption with these cutaneous findings. What is the antigenic target of the autoantibodies generated in this condition
A. NC16A of BPAg1
B. NC16A of BPAg2
C. C-terminal of BPAg1
D. C-terminal of BPAg2
E. alpha-6-beta-4 integrin
To find out the correct answer and read t …